AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 117 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $235,000 | +123.8% | 3,930 | +4.9% | 0.01% | +100.0% |
| Q3 2019 | $105,000 | -26.1% | 3,746 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $142,000 | +18.3% | 3,746 | +21.6% | 0.01% | 0.0% |
| Q1 2019 | $120,000 | +126.4% | 3,081 | +23.4% | 0.01% | +100.0% |
| Q4 2018 | $53,000 | -46.5% | 2,496 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $99,000 | +4.2% | 2,496 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $95,000 | +86.3% | 2,496 | +47.3% | 0.01% | +150.0% |
| Q1 2018 | $51,000 | +21.4% | 1,694 | +26.5% | 0.00% | 0.0% |
| Q4 2017 | $42,000 | +50.0% | 1,339 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $28,000 | +7.7% | 1,339 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $26,000 | +271.4% | 1,339 | +228.2% | 0.00% | – |
| Q1 2017 | $7,000 | – | 408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |